Literature DB >> 8114358

Nitric oxide mediates cat hindlimb cholinergic vasodilation induced by stimulation of posterior hypothalamus.

K Matsukawa1, T Shindo, M Shirai, I Ninomiya.   

Abstract

The aim of this work was to examine whether endothelium-derived relaxing factor (nitric oxide) mediates cat hindlimb cholinergic vasodilation induced by stimulation of the posterior hypothalamus and beta-adrenergic vasodilation by I.V. injection of isoproterenol using an inhibitor of nitric oxide synthesis, NW-nitro-L-arginine methyl ester (L-NAME). Without L-NAME, femoral blood flow velocity (FBV) increased during hypothalamic stimulation by 11.2 +/- 2.2 cm/s (mean +/- SEM) from the baseline value of 8.4 +/- 2.2 cm/s and femoral conductance (FC) increased by 0.084 +/- 0.021 cm/s/mmHg from 0.062 +/- 0.016 cm/s/mmHg, which were abolished by atropine (0.5 mg I.A.). Arterial blood pressure (AP) and heart rate (HR) increased during hypothalamic stimulation (15 +/- 8 mmHg and 22 +/- 6 beats/min). When isoproterenol (1-2 micrograms I.V.) was injected, FBV and FC increased 5.1 +/- 0.56 cm/s and 0.048 +/- 0.005 cm/s/mmHg. With L-NAME (20-100 mg I.A.), the rises in AP and HR during hypothalamic stimulation were unchanged but the increases in FBV and FC were significantly blunted to 5.2 +/- 3.7 cm/s and 0.026 +/- 0.021 cm/s/mmHg. In contrast, L-NAME did not affect the responses in FBV and FC during stimulation of beta-adrenergic receptors. The effect of NG-monomethyl-L-arginine (10-30 mg I.A.) was the same as L-NAME. It is suggested that nitric oxide is involved in hindlimb cholinergic vasodilation neurally induced by hypothalamic stimulation but not in beta-adrenergic vasodilation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8114358     DOI: 10.2170/jjphysiol.43.473

Source DB:  PubMed          Journal:  Jpn J Physiol        ISSN: 0021-521X


  9 in total

Review 1.  Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs.

Authors:  Michael J Joyner; Darren P Casey
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Exercise hyperaemia: is anything obligatory but the hyperaemia?

Authors:  Michael J Joyner; Brad W Wilkins
Journal:  J Physiol       Date:  2007-07-19       Impact factor: 5.182

3.  Evidence for nitric oxide-mediated sympathetic forearm vasodiolatation in humans.

Authors:  N M Dietz; K A Engelke; T T Samuel; R T Fix; M J Joyner
Journal:  J Physiol       Date:  1997-01-15       Impact factor: 5.182

4.  Forearm sympathetic withdrawal and vasodilatation during mental stress in humans.

Authors:  J R Halliwill; L A Lawler; T J Eickhoff; N M Dietz; L A Nauss; M J Joyner
Journal:  J Physiol       Date:  1997-10-01       Impact factor: 5.182

5.  Skeletal muscle vasodilatation during sympathoexcitation is not neurally mediated in humans.

Authors:  A S Reed; M E Tschakovsky; C T Minson; J R Halliwill; K D Torp; L A Nauss; M J Joyner
Journal:  J Physiol       Date:  2000-05-15       Impact factor: 5.182

6.  Direct observations of sympathetic cholinergic vasodilatation of skeletal muscle small arteries in the cat.

Authors:  K Matsukawa; T Shindo; M Shirai; I Ninomiya
Journal:  J Physiol       Date:  1997-04-01       Impact factor: 5.182

7.  Electrical stimulation of the mesencephalic ventral tegmental area evokes skeletal muscle vasodilatation in the cat and rat.

Authors:  Kanji Matsukawa; Tomoko Nakamoto; Nan Liang
Journal:  J Physiol Sci       Date:  2011-05-04       Impact factor: 2.781

8.  Have we missed that neural vasodilator mechanisms may contribute to exercise hyperemia at onset of voluntary exercise?

Authors:  Kanji Matsukawa; Kei Ishii; Nan Liang; Kana Endo
Journal:  Front Physiol       Date:  2013-02-15       Impact factor: 4.566

9.  Evidence for centrally induced cholinergic vasodilatation in skeletal muscle during voluntary one-legged cycling and motor imagery in humans.

Authors:  Kei Ishii; Kanji Matsukawa; Nan Liang; Kana Endo; Mitsuhiro Idesako; Hironobu Hamada; Kazumi Ueno; Tsuyoshi Kataoka
Journal:  Physiol Rep       Date:  2013-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.